VRPX
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
VRPX
Delisted
VRPX was delisted on the 3rd of April, 2025.
9 hedge funds and large institutions have $66.8K invested in Virpax Pharmaceuticals, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.
Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$21.8K |
| 2 |
2
Geode Capital Management
Boston,
Massachusetts
|
$19.4K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$14.2K |
| 4 |
TSS
4
Two Sigma Securities
New York
|
$8.7K |
| 5 |
TRCT
5
Tower Research Capital (TRC)
New York
|
$2.66K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $21.8K | 31,382 | +31,382 | New |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $19.4K | 27,971 | +27,971 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $14.2K | 20,435 | +19,348 | +1,780% |
|
|
TSS
4
Two Sigma Securities
New York
| $8.7K | 12,522 | +12,522 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $2.66K | 3,837 | +691 | +22% |
|
|
SRCM
6
Signature Resources Capital Management
Newport Beach,
California
| $35 | 50 | – | – |
|
7
Bank of America
Charlotte,
North Carolina
| $26 | 37 | +30 | +429% |
|
8
Morgan Stanley
New York
| $10 | 15 | – | – |
|
|
WAM
9
Warberg Asset Management
Winnetka,
Illinois
| – | – | -20,000 | Closed |
|
|
PA
10
Parallel Advisors
San Francisco,
California
| – | – | -1 | Closed |
|
|
HFS
11
Hantz Financial Services
Southfield,
Michigan
| $0 | 10 | – | – |
|
|
CFGS
12
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|